Evogene (EVGN) has released an update.
Evogene Ltd. has announced the issuance of Series A Ordinary Share Purchase Warrants, allowing holders to purchase shares at a predetermined price until a specified termination date in August 2029. The warrants, which are subject to specific terms and conditions, are not registered with the SEC and can only be traded in compliance with applicable securities laws. Holders can exercise their purchase rights electronically without needing to physically surrender the warrant until all shares are acquired.
For further insights into EVGN stock, check out TipRanks’ Stock Analysis page.
